Press Coverage

Patient story: Cellvizio was used to speed up diagnosis and to enable faster treatment and care

19 November 2014

Ben Carlsen is 36 years old and has been living with lung cancer for the last six months. He was referred to Dr. Aki at the Lung Center at Valley View where he experienced technology that combines detection, diagnosis and staging in one procedure. A GPS-like technology was used to locate, test and detect a lesion in the lung, and Cellvizio Confocal Endomicroscopy enabled his pulmonologist to see individual cells in the farthest reaches of his lungs.

Latest News

Mauna Kea Technologies Reports First Half 2025 Revenue 

Mauna Kea Technologies Reports First Half 2025 Revenue 

Mauna Kea Technologies Enters Australian Market with Endotherapeutics Partnership 

Mauna Kea Technologies Enters Australian Market with Endotherapeutics Partnership 

Mauna Kea Technologies Strengthens its Leading Role in the AI-based Endomicroscopic Imaging Ecosystem with its 14th Patent Granted in the U.S. 

Mauna Kea Technologies Strengthens its Leading Role in the AI-based Endomicroscopic Imaging Ecosystem with its 14th Patent Granted in the U.S. 

No results found.